Latest news with #Frahm
Business Insider
6 days ago
- Business
- Business Insider
Blueprint Medicines (BPMC) was downgraded to a Hold Rating at TD Cowen
TD Cowen analyst Marc Frahm downgraded Blueprint Medicines (BPMC – Research Report) to a Hold today and set a price target of $130.00. Confident Investing Starts Here: Frahm covers the Healthcare sector, focusing on stocks such as Incyte, Inozyme Pharma, and Xilio Therapeutics. According to TipRanks, Frahm has an average return of 3.7% and a 39.53% success rate on recommended stocks. In addition to TD Cowen, Blueprint Medicines also received a Hold from J.P. Morgan's Brian Cheng in a report issued today. However, on the same day, Citi reiterated a Sell rating on Blueprint Medicines (NASDAQ: BPMC). The company has a one-year high of $121.90 and a one-year low of $73.04. Currently, Blueprint Medicines has an average volume of 988.3K. Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BPMC in relation to earlier this year. Most recently, in March 2025, Jeffrey Albers, a Director at BPMC sold 5,766.00 shares for a total of $512,020.80.
Yahoo
17-05-2025
- Yahoo
‘Probably a first for Wautoma': Man arrested for soliciting Dollar General employees for sex
WAUTOMA, Wis. (WFRV) – In what the Chief of Police called 'probably a first for the City of Wautoma,' a man was arrested for soliciting prostitution from two Dollar General employees because a 'farmer was willing to pay to watch.' According to the Wautoma Police Department, officers were called to a Dollar General on May 14 for reports of a man soliciting employees to perform sex acts in exchange for money. Inmate in Green Bay accused of threatening to cut Donald Trump's body up into 'small chunks' has cash bond set at $50k Officers say the man, later identified as 35-year-old Wautoma resident Joshua Frahm, approached two women in the store and requested a sex act in exchange for money. After they refused, he left, but returned shortly after to offer more money. One of the victims was able to provide a description of his vehicle, which was later found at a Wautoma Kwik Trip. While Frahm was interviewed, he reportedly admitted to the previous accusations. Allegedly further saying that he solicited the women 'because a farmer from Saxeville was willing to pay him to watch the sex acts.' Wisconsin man arrested at his workplace for possession of child pornography This is probably a first for the City of Wautoma, our Kwik Trip and our Dollar General. Our agency cannot recall any prior arrest for soliciting prostitution in the history of the department. We are grateful for the quick thinking employees of Dollar General who were able to provide information that led to the suspects arrest. Paul Mott, Chief of Police Wautoma Police Department The Dollar General employees also suggested that he may have approached other women in the area. Frahm had a court appearance on May 16 and is being held on two counts of Soliciting Prostitution and Disorderly Conduct. Solicitation is a Class H felony and is punishable by up to six years imprisonment. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Business Insider
13-05-2025
- Business
- Business Insider
TD Cowen Remains a Buy on Black Diamond Therapeutics (BDTX)
In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Black Diamond Therapeutics (BDTX – Research Report). The company's shares closed today at $1.75. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Frahm covers the Healthcare sector, focusing on stocks such as Incyte, Kymera Therapeutics, and Janux Therapeutics Inc. According to TipRanks, Frahm has an average return of -0.3% and a 33.56% success rate on recommended stocks. Currently, the analyst consensus on Black Diamond Therapeutics is a Strong Buy with an average price target of $13.50. The company has a one-year high of $6.75 and a one-year low of $1.20. Currently, Black Diamond Therapeutics has an average volume of 3.32M. Based on the recent corporate insider activity of 18 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BDTX in relation to earlier this year. Most recently, in March 2025, BIOTECH GROWTH N V, a Major Shareholder at BDTX sold 5,784,292.00 shares for a total of $11,972,369.40.
